- Home
- ANEB vs GROW Comparison
ANEB vs GROW Comparison
Compare ANEB & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANEB | GROW |
|---|---|---|
| Founded | 2020 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 96.8M | 32.2M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ANEB | GROW |
|---|---|---|
| Price | $1.93 | $2.41 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 16.2K | ★ 43.8K |
| Earning Date | 11-13-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 3.75% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | N/A | ★ $8,546,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $36.81 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.80 | $2.02 |
| 52 Week High | $3.42 | $2.78 |
Technical Indicators
Market Signals| Indicator | ANEB | GROW |
|---|---|---|
| Relative Strength Index (RSI) | 43.86 | 48.20 |
| Support Level | $2.16 | $2.33 |
| Resistance Level | $2.30 | $2.50 |
| Average True Range (ATR) | 0.14 | 0.07 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 59.81 | 47.12 |
Price Performance
Historical ComparisonAbout ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies. Anebulo Pharmaceuticals operates in one segment, exclusively in the United States.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.